BMO Capital analyst Michael Zaremski raised the firm’s price target on Skyward Specialty Insurance (SKWD) to $55 from $52 and keeps a Market Perform rating on the shares. The company’s near-term ROE profile should improve given that it continues to grow into an attractive, but decelerating excess & surplus cycle, though the firm’s target price upside is tempered by Skyward potentially showing reserving potholes similar to peers, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKWD:
- Skyward Specialty Insurance price target raised to $70 from $65 at Citizens JMP
- Skyward Specialty Insurance to acquire 100% of Apollo Group Holdings for $555M
- Skyward Specialty’s Earnings Call: Record Income and Growth
- Skyward Specialty Insurance price target lowered to $59 from $69 at Piper Sandler
- Skyward Specialty Insurance Sees Strong Q2 2025 Growth
